ArticleBreast cancer research : BCR2022

Deep whole genome sequencing identifies recurrent genomic alterations in commonly used breast cancer cell lines and patient-derived xenograft models.

Niantao Deng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.